No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Wednesday, October 22, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

Amanta Healthcare IPO: Amanta Healthcare shares to list tomorrow. Here’s what GMP indicates ahead of debut

by TheAdviserMagazine
1 month ago
in Business
Reading Time: 2 mins read
A A
Amanta Healthcare IPO: Amanta Healthcare shares to list tomorrow. Here’s what GMP indicates ahead of debut
Share on FacebookShare on TwitterShare on LInkedIn


Ahmedabad-based Amanta Healthcare is set to make its market debut on Tuesday. Ahead of the listing, the GMP is quoting at about Rs 9 over the upper end of the issue price of Rs 126. That works out to a 7% premium, indicating modest but steady demand in the unofficial market. The Rs 126 crore public offer of Amanta Healthcare was open for subscription between September 1 and September 3.

The issue was entirely a fresh share sale, with the company issuing about one crore shares. The price band was fixed at Rs 120–126 per share. Post issue, promoter shareholding will reduce from 85.6% to 63.6%, signalling a reasonable dilution for growth funding.

Company backgroundFounded in 1994, Amanta Healthcare develops and markets sterile liquid pharmaceutical products and medical devices. Its product basket includes large and small volume parenterals (IV fluids and injectables), ophthalmic solutions, respiratory care products and irrigation fluids. The company also manufactures medical devices such as first-aid solutions and eye lubricants.

Also Read: 9 IPOs opening this week see GMPs from 0 to 107%. Check for all issues

It operates a large facility in Hariyala, Kheda district, Gujarat, with advanced manufacturing lines based on Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technology. With over 45 generics marketed under its own brands, the company sells across India through 320 distributors and also exports to Africa, Latin America, the UK, and 19 other countries.

Live Events

Financials and growth strategyAmanta’s revenue stood at Rs 274.7 crore in FY25, almost flat year-on-year, while profit after tax rose sharply to Rs 10.5 crore from Rs 3.6 crore in FY24. Margins improved with EBITDA at Rs 59.6 crore, translating into an EBITDA margin of over 21%.The company plans to use Rs 70 crore from the IPO proceeds for a new SteriPort manufacturing line and about Rs 30 crore for a new SVP line, while the rest will go toward general corporate purposes.The strategy is to deepen branded generics sales under its SteriPort brand, expand international reach, and add manufacturing capacity to ease current supply constraints.

OutlookAnalysts say the IPO is priced at about 47x FY25 earnings on a post-issue basis, making valuations appear expensive compared to some listed peers. Still, investors are betting on the company’s strong presence in sterile injectables and its export-led growth.

With a GMP of around 7%, expectations for listing gains remain moderate. The stock’s actual performance will depend on sustained demand for parenterals and how quickly the company can scale up its new manufacturing lines.

Add ET Logo as a Reliable and Trusted News Source



Source link

Tags: AheadAmantadebutGMPhealthcareHeresIPOListsharesTomorrow
ShareTweetShare
Previous Post

Items That Are A Complete Waste of Money

Next Post

Alibaba leads $100 million investment in Chinese humanoid robot startup

Related Posts

edit post
Navan to aim for -8b valuation in Nasdaq IPO next week

Navan to aim for $7-8b valuation in Nasdaq IPO next week

by TheAdviserMagazine
October 22, 2025
0

Travel booking company Navan, formerly TripActions, will reportedly hold its IPO on Nasdaq next week at a company valuation...

edit post
Where Will It Be in 1 Year (Oct 22)

Where Will It Be in 1 Year (Oct 22)

by TheAdviserMagazine
October 22, 2025
0

2024 Getty Images / Getty Images Entertainment via Getty Images Shares of Rivian Automotive Inc. (NASDAQ: RIVN) are changing hands...

edit post
Willing to pay extra to build resilience in our supply chains: Piyush Goyal

Willing to pay extra to build resilience in our supply chains: Piyush Goyal

by TheAdviserMagazine
October 22, 2025
0

New Delhi: Commerce and Industry Minister Piyush Goyal on Wednesday said the government is addressing supply chain issues across all...

edit post
The U.S. government shutdown means investors are flying blind when it comes to high-quality data—and they like it that way

The U.S. government shutdown means investors are flying blind when it comes to high-quality data—and they like it that way

by TheAdviserMagazine
October 22, 2025
0

The U.S. government shutdown has halted federal economic data collection, leaving investors without official employment or inflation figures. Despite flying...

edit post
Germany to buy Rafael Spike missiles for €2b

Germany to buy Rafael Spike missiles for €2b

by TheAdviserMagazine
October 22, 2025
0

The German Army has decided to procure Spike missiles from Israel’s Rafael Advanced Defense Systems for €2 billion. The...

edit post
Genflow Biosciences announces second European patent application (GENFF:OTCMKTS)

Genflow Biosciences announces second European patent application (GENFF:OTCMKTS)

by TheAdviserMagazine
October 22, 2025
0

Genflow Biosciences (OTCQB:GENFF) on Wednesday announced that its second European patent application (Application No. 23821586.7, Publication No. EP4630038), titled "SIRT6...

Next Post
edit post
Alibaba leads 0 million investment in Chinese humanoid robot startup

Alibaba leads $100 million investment in Chinese humanoid robot startup

edit post
Critics argue Stripe’s blockchain ambitions clashes with crypto decentralization

Critics argue Stripe's blockchain ambitions clashes with crypto decentralization

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

October 9, 2025
edit post
Navan to aim for -8b valuation in Nasdaq IPO next week

Navan to aim for $7-8b valuation in Nasdaq IPO next week

0
edit post
India, U.S. near trade deal with major tariff cuts, reduced Russian oil purchases

India, U.S. near trade deal with major tariff cuts, reduced Russian oil purchases

0
edit post
Robinhood lists BNB token

Robinhood lists BNB token

0
edit post
A wish list for Carney’s fall budget

A wish list for Carney’s fall budget

0
edit post
Usa Rare Earth (USAR): Dreht die Seltene-Erden-Aktie am kritischen 25-USD-Support?

Usa Rare Earth (USAR): Dreht die Seltene-Erden-Aktie am kritischen 25-USD-Support?

0
edit post
Workers Shed Light on the Biggest Shifts in the Workplace Now

Workers Shed Light on the Biggest Shifts in the Workplace Now

0
edit post
Navan to aim for -8b valuation in Nasdaq IPO next week

Navan to aim for $7-8b valuation in Nasdaq IPO next week

October 22, 2025
edit post
Robinhood lists BNB token

Robinhood lists BNB token

October 22, 2025
edit post
Usa Rare Earth (USAR): Dreht die Seltene-Erden-Aktie am kritischen 25-USD-Support?

Usa Rare Earth (USAR): Dreht die Seltene-Erden-Aktie am kritischen 25-USD-Support?

October 22, 2025
edit post
Beyond Meat shares surge as meme traders buy stock

Beyond Meat shares surge as meme traders buy stock

October 22, 2025
edit post
Where Will It Be in 1 Year (Oct 22)

Where Will It Be in 1 Year (Oct 22)

October 22, 2025
edit post
Willing to pay extra to build resilience in our supply chains: Piyush Goyal

Willing to pay extra to build resilience in our supply chains: Piyush Goyal

October 22, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Navan to aim for $7-8b valuation in Nasdaq IPO next week
  • Robinhood lists BNB token
  • Usa Rare Earth (USAR): Dreht die Seltene-Erden-Aktie am kritischen 25-USD-Support?
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.